Article Sidebar

Submitted
October 21, 2024
Accepted
October 21, 2024
Published
October 21, 2024
Download
PDF
Statistic
Read Counter : 592 Download : 432

Main Article Content

Abstract

Background: Non-alcoholic fatty liver disease (NAFLD) is a prevalent condition commonly
observed in depressive patients.
Objective: this randomized clinical trial aimed to investigate the effects of multivitamin
supplementation on liver enzymes in depressive patients with NAFLD.
Methods: The study randomly divided the participants into two groups: the intervention group,
which received multivitamin supplementation, and the control group, which received a placebo.
The researchers examined liver enzymes such as alanine aminotransferase (ALT), aspartate
aminotransferase (AST), alkaline phosphatase (ALP), and serum bilirubin to evaluate liver
function. They conducted statistical analyses to compare the changes in the levels of these liver
enzymes between the two groups.
Results: The results demonstrated that the multivitamin supplementation group showed a
statistically significant decrease in ALT, AST, ALP and serum bilirubin levels compared to the
placebo group. Also results showed that the multivitamin supplementation group exhibited
significant improvements in depressive symptom scores compared to the placebo group.
Conclusion: The results of this study indicate that multivitamin supplementation could
potentially improve liver function in individuals with non-alcoholic fatty liver disease (NAFLD)
who also suffer from depression. However, additional research is needed to investigate the
underlying mechanisms and long-term impacts of multivitamin supplementation on liver health
specifically in this group of patients.

Keywords

Non-alcoholic fatty liver disease NAFLD depression

Article Details

License

Copyright (c) 2024 University of Thi-Qar Journal Of Medicine

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

References

  1. Pouwels S, Sakran N, Graham Y, Leal A, Pintar T, Yang W, et al. Non-alcoholic fatty liver disease
  2. (NAFLD): a review of pathophysiology, clinical management and effects of weight loss. BMC Endocr
  3. Disord. 2022;22(1):63.
  4. Shea S, Lionis C, Kite C, Atkinson L, Chaggar SS, Randeva HS, et al. Non-Alcoholic Fatty Liver
  5. Disease (NAFLD) and Potential Links to Depression, Anxiety, and Chronic Stress. Biomedicines.
  6. ;9(11).
  7. Liu C, Shao M, Lu L, Zhao C, Qiu L, Liu Z. Obesity, insulin resistance and their interaction on
  8. liver enzymes. PLoS One. 2021;16(4):e0249299.
  9. Kwak MS, Kim D. Non-alcoholic fatty liver disease and lifestyle modifications, focusing on
  10. physical activity. Korean J Intern Med. 2018;33(1):64-74.
  11. Yetley EA. Multivitamin and multimineral dietary supplements: definitions, characterization,
  12. bioavailability, and drug interactions2. The American Journal of Clinical Nutrition. 2007;85(1):269S-76S.
  13. Abe RAM, Masroor A, Khorochkov A, Prieto J, Singh KB, Nnadozie MC, et al. The Role of
  14. Vitamins in Non-Alcoholic Fatty Liver Disease: A Systematic Review. Cureus. 2021;13(8):e16855.
  15. Raza S, Tewari A, Rajak S, Sinha RA. Vitamins and non-alcoholic fatty liver disease: A molecular
  16. insight. Liver Research. 2021;5(2):62-71.
  17. He Z, Li X, Yang H, Wu P, Wang S, Cao D, et al. Effects of Oral Vitamin C Supplementation on
  18. Liver Health and Associated Parameters in Patients With Non-Alcoholic Fatty Liver Disease: A
  19. Randomized Clinical Trial. Frontiers in Nutrition. 2021;8.
  20. Chen Q, Zhao L, Mei L, Zhao X, Han P, Liu J, et al. Vitamin C and vitamin D3 alleviate metabolicassociated fatty liver disease by regulating the gut microbiota and bile acid metabolism via the gut-liver
  21. axis. Frontiers in Pharmacology. 2023;14.
  22. Grinberg L, Dabbah Assadi F, Baum G, Zemel R, Tur-Kaspa R, Shochat C, et al. Beneficial Effect
  23. of Vitamin D on Non-Alcoholic Fatty Liver Disease (NAFLD) Progression in the Zebrafish Model.
  24. Nutrients. 2023;15(6):1362.
  25. Hassanzadeh Rad A, Salehi S, Maleknejad S, Fakhre Yaseri A. The Latest Evidence on the
  26. Association Between Vitamins and Non-alcoholic Fatty Liver Disease in Childhood. J Compr Ped.
  27. ;14(1):e133596.
  28. Wareham NJ, Jakes RW, Rennie KL, Schuit J, Mitchell J, Hennings S, et al. Validity and
  29. repeatability of a simple index derived from the short physical activity questionnaire used in the European
  30. Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr. 2003;6(4):407-13.
  31. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013
  32. AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the
  33. American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The
  34. Obesity Society. J Am Coll Cardiol. 2014;63(25 Pt B):2985-3023.
  35. Patti G, Pellegrino C, Ricciardi A, Novara R, Cotugno S, Papagni R, et al. Potential Role of
  36. Vitamins A, B, C, D and E in TB Treatment and Prevention: A Narrative Review. Antibiotics (Basel).
  37. ;10(11).
  38. Peng H, Wang M, Pan L, Cao Z, Yao Z, Chen Q, et al. Associations of serum multivitamin levels
  39. with the risk of non-alcoholic fatty liver disease: A population-based cross-sectional study in U.S. adults.
  40. Front Nutr. 2022;9:962705.
  41. Hong HC, Lee J-S, Choi HY, Yang SJ, Yoo HJ, Seo JA, et al. Liver enzymes and vitamin D levels
  42. in metabolically healthy but obese individuals: Korean National Health and Nutrition Examination Survey.
  43. Metabolism - Clinical and Experimental. 2013;62(9):1305-12.
  44. Dong B, Zhou Y, Wang W, Scott J, Kim K, Sun Z, et al. Vitamin D Receptor Activation in Liver
  45. Macrophages Ameliorates Hepatic Inflammation, Steatosis, and Insulin Resistance in Mice. Hepatology.
  46. ;71(5):1559-74.
  47. Matough FA, Budin SB, Hamid ZA, Alwahaibi N, Mohamed J. The role of oxidative stress and
  48. antioxidants in diabetic complications. Sultan Qaboos Univ Med J. 2012;12(1):5-18.
  49. Petermann-Rocha F, Wirth MD, Boonpor J, Parra-Soto S, Zhou Z, Mathers JC, et al. Associations
  50. between an inflammatory diet index and severe non-alcoholic fatty liver disease: a prospective study of
  51. ,544 UK Biobank participants. BMC Medicine. 2023;21(1):123.
  52. Wei J, Lei G-h, Fu L, Zeng C, Yang T, Peng S-f. Association between Dietary Vitamin C Intake
  53. and Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study among Middle-Aged and Older Adults.
  54. PLOS ONE. 2016;11(1):e0147985.
  55. Liu X, Shen H, Chen M, Shao J. Clinical Relevance of Vitamins and Carotenoids With Liver
  56. Steatosis and Fibrosis Detected by Transient Elastography in Adults. Frontiers in Nutrition. 2021;8.
  57. Xie Z-Q, Li H-X, Tan W-L, Yang L, Ma X-W, Li W-X, et al. Association of Serum Vitamin C
  58. With NAFLD and MAFLD Among Adults in the United States. Frontiers in Nutrition. 2022;8.
  59. Jeon D, Son M, Shim J. Dynamics of Serum Retinol and Alpha-Tocopherol Levels According to
  60. Non-Alcoholic Fatty Liver Disease Status. Nutrients. 2021;13(5):1720.
  61. Lim U, Turner SD, Franke AA, Cooney RV, Wilkens LR, Ernst T, et al. Predicting Total,
  62. Abdominal, Visceral and Hepatic Adiposity with Circulating Biomarkers in Caucasian and Japanese
  63. American Women. PLOS ONE. 2012;7(8):e43502.
  64. Wallström P, Wirfält E, Lahmann PH, Gullberg B, Janzon L, Berglund G. Serum concentrations
  65. of beta-carotene and alpha-tocopherol are associated with diet, smoking, and general and central adiposity.
  66. Am J Clin Nutr. 2001;73(4):777-85.
  67. Waniek S, Di Giuseppe R, Plachta-Danielzik S, Ratjen I, Jacobs G, Koch M, et al. Association of
  68. Vitamin E Levels with Metabolic Syndrome, and MRI-Derived Body Fat Volumes and Liver Fat Content.
  69. Nutrients. 2017;9(10):1143

Similar Articles

You may also start an advanced similarity search for this article.